ClosedPublished 31 May 2024

Allogene Overland Biopharm (CY) Limited /
Overland Pharmaceuticals

Allogene Overland JV takes ownership of Overland US business

Buy side: Allogene Overland Biopharm (CY) Limited
Buy sideAllogene Overland Biopharm (CY) Limited
Target: Overland Pharmaceuticals
TargetOverland Pharmaceuticals
Source · 31 May 2024Source-verified
Buy side: Allogene Overland Biopharm (CY) Limited
Buy sideAllogene Overland Biopharm (CY) Limited
Target: Overland Pharmaceuticals
TargetOverland Pharmaceuticals
01 / BuyerAllogene Overland Biopharm (CY) Limited
02 / TargetOverland Pharmaceuticals
Source-verified
01

What happened

Allogene Overland Biopharm (CY) Limited acquired a 100% equity interest in Overland Pharmaceuticals (US) Inc. as part of a share exchange with Overland Pharmaceuticals (CY) Inc. The transaction has closed.

Overland US includes research and development, clinical and administrative staff, along with cell therapy assets and its OL-101 program.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Allogene Overland JV takes ownership of Overland US business

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.